ExodusPoint Capital Management’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-18,265
| Closed | -$138K | – | 2046 |
|
|
2023
Q2 | $138K | Sell |
18,265
-331,735
| -95% | -$2.51M | ﹤0.01% | 1642 |
|
|
2023
Q1 | $3.1M | Buy |
350,000
+333,869
| +2,070% | +$2.96M | 0.03% | 616 |
|
|
2022
Q4 | $147K | Sell |
16,131
-9,267
| -36% | -$84.4K | ﹤0.01% | 1439 |
|
|
2022
Q3 | $205K | Buy |
25,398
+8,100
| +47% | +$65.4K | ﹤0.01% | 1599 |
|
|
2022
Q2 | $130K | Buy |
+17,298
| New | +$130K | ﹤0.01% | 1666 |
|
|
2022
Q1 | – | Sell |
-92,823
| Closed | -$744K | – | 2608 |
|
|
2021
Q4 | $744K | Buy |
+92,823
| New | +$744K | 0.01% | 1184 |
|
|
2021
Q3 | – | Sell |
-52,641
| Closed | -$521K | – | 2536 |
|
|
2021
Q2 | $521K | Buy |
+52,641
| New | +$521K | 0.01% | 1292 |
|
|
2020
Q4 | – | Sell |
-58,858
| Closed | -$530K | – | 2283 |
|
|
2020
Q3 | $530K | Buy |
+58,858
| New | +$530K | 0.01% | 927 |
|
|
2020
Q2 | – | Sell |
-22,864
| Closed | -$205K | – | 1982 |
|
|
2020
Q1 | $205K | Sell |
22,864
-19,589
| -46% | -$176K | 0.01% | 739 |
|
|
2019
Q4 | $416K | Buy |
42,453
+22,253
| +110% | +$218K | 0.01% | 919 |
|
|
2019
Q3 | $139K | Buy |
+20,200
| New | +$139K | ﹤0.01% | 1166 |
|
|
2019
Q1 | – | Sell |
-135,144
| Closed | -$2.08M | – | 759 |
|
|
2018
Q4 | $2.08M | Buy |
+135,144
| New | +$2.08M | 0.15% | 55 |
|